Northwestern Mutual Wealth Management
CUE icon

Northwestern Mutual Wealth Management’s Cue Biopharma CUE Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83.1K Sell
2,632
-18
-0.7% -$407 ﹤0.01% 2339
2026
Q1 		$18.3K Hold
2,650
– – ﹤0.01% 2836
2025
Q4 		$24.3K Hold
2,650
– – ﹤0.01% 2668
2025
Q3 		$57.1K Sell
2,650
-117
-4% -$2.75K ﹤0.01% 2273
2025
Q2 		$56.6K Buy
2,767
+2,434
+731% +$51.9K ﹤0.01% 2204
2025
Q1 		$9.11K Buy
333
+250
+301% +$9.28K ﹤0.01% 2776
2024
Q4 		$2.73K Hold
83
– – ﹤0.01% 3106
2024
Q3 		$1.89K Buy
83
+66
+388% +$1.43K ﹤0.01% 3127
2024
Q2 		$620 Hold
17
– – ﹤0.01% 3264
2024
Q1 		$945 Sell
17
-12
-41% -$846 ﹤0.01% 3194
2023
Q4 		$2.28K Buy
29
+12
+71% +$858 ﹤0.01% 3035
2023
Q3 		$1.15K Hold
17
– – ﹤0.01% 3022
2023
Q2 		$1.82K Buy
+17
New +$2K ﹤0.01% 3001
2022
Q1 		– Sell
-2
Closed -$1K – 3162
2021
Q4 		$1K Buy
+2
New +$773 ﹤0.01% 3014

Other funds holding CUE

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM

Northwestern Mutual Wealth Management's CUE Position: Q2 2026 in Review

Northwestern Mutual Wealth Management reduced its Cue Biopharma (CUE) stake by 0.68% in Q2 2026, selling an estimated $407 and leaving 2,632 shares worth $83.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2339.

Northwestern Mutual Wealth Management first reported a position in CUE in Q4 2021 and has held it in 14 quarters since. 50 funds tracked by Wall St. Rank hold CUE as of Q2 2026.

  • Northwestern Mutual Wealth Management held 2,632 shares of Cue Biopharma worth $83.1K as of Q2 2026.
  • Northwestern Mutual Wealth Management sold 18 Cue Biopharma shares in Q2 2026, an estimated $407.
  • Cue Biopharma made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #2339 holding.
  • Northwestern Mutual Wealth Management first reported a position in Cue Biopharma in Q4 2021 and has held it in 14 quarters since.
  • 50 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.